ReviewClinical immunology (Orlando, Fla.)2021

ROCK2, a critical regulator of immune modulation and fibrosis has emerged as a therapeutic target in chronic graft-versus-host disease.

Alexandra Zanin-Zhorov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.